Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

BACKGROUND: Observational data and preliminary studies suggest serotonin 2A agonist psychedelics may hold potential in treating a variety of substance use disorders (SUDs), including opioid use disorder (OUD). AIMS: The study aim was to describe and analyze self-reported cases in which naturalistic...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Romeu, Albert, Davis, Alan K., Erowid, Earth, Erowid, Fire, Griffiths, Roland R., Johnson, Matthew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987443/
https://www.ncbi.nlm.nih.gov/pubmed/32038317
http://dx.doi.org/10.3389/fpsyt.2019.00955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987443/
https://www.ncbi.nlm.nih.gov/pubmed/32038317
http://dx.doi.org/10.3389/fpsyt.2019.00955

Ejemplares similares